Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Keyword
Search by Category
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

119 Results

  • Product Image: The Role of Senescent Cells in Skeletal Aging and Repair

    The Role of Senescent Cells in Skeletal Aging and Repair
    Contains 1 Component(s) Includes a Live Web Event on 09/29/2026 at 2:00 PM (EDT)

    Join Dr. Sundeep Khosla as they discuss "The role of senescent cells in skeletal aging and repair " moderated by Dr. Matthew Prideaux

    Join Dr. Sundeep Khosla as they discuss "The role of senescent cells in skeletal aging and repair " moderated by Dr. Matthew Prideaux

    Learning Objectives:
    1. Understand mechanisms driving cellular senescence in bone and other tissues
    2. Define consequences of global and cell-specific senescent cell clearance on the skeleton
    3. Define differences in mesenchymal versus immune cell senescent phenotypes
    4. Describe progress and challenges to clinical translation of senolytic

    This webinar is hosted by the ASBMR Muscle and Bone Disease Scientific Interest Group (SIG). The Scientific Interest Groups, brought to you by the Membership Engagement Committee (MEC), aim to empower members through fostering meaningful engagement and collaboration within specific research areas. SIGs are dedicated to promoting year-round connectivity, enhancing networking opportunities, and facilitating mentorship that advances careers. By ensuring inclusivity for all members, SIGs strive to provide exclusive benefits that extend beyond our Annual Meeting, creating a vibrant and supportive community for all.

    Dr. Sundeep Khosla

    Dr. Sundeep Khosla

    MD

    Dr. Sundeep Khosla is the Dr. Francis Chucker and Nathan Landow Research Professor of Medicine and Physiology and a Mayo Foundation Distinguished Investigator. Dr. Khosla received his A.B. degree from Harvard College and his M.D. from Harvard Medical School. He was subsequently a resident in Internal Medicine and a fellow in Endocrinology at the Massachusetts General Hospital. In 1988 he moved to Mayo Clinic, where his research has focused on mechanisms of age-related bone loss and osteoporosis. Dr. Khosla has served as Director of the Center for Clinical and Translational Science and Dean for Clinical and Translational Science at Mayo Clinic. He has also served as Chair of the NIH SBDD Study Section, on the Councils of the National Institute on Aging and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and as President of the American Society for Bone and Mineral Research (ASBMR). Dr. Khosla has received numerous awards and honors for his work, including the Frederic C. Bartter Award for Clinical Investigation and the William F. Neuman Award for Outstanding Scientific Contributions from the ASBMR, the presentation of the Louis V. Avioli Plenary Lecture at the ASBMR annual meeting, the Outstanding Clinical Investigator Award and Plenary Lecture from the Endocrine Society, the Frontiers in Science Award from the American Association of Clinical Endocrinologists, the Jacobaeus Prize for outstanding research in Endocrinology, and election to the ASCI and AAP.  Dr. Khosla has served as the Editor-in-Chief of Bone, as Associate Editor of the Journal of Bone and Mineral Research and as a member of the editorial boards for the Journal of Clinical Investigation, Journal of Bone and Mineral Research, Journal of Clinical Endocrinology and Metabolism, Bone, and Endocrine Reviews.

    Dr. Matthew Prideaux

    Dr. Matthew Prideaux (Moderator)

    Ph.D

  • Product Image: Effects of Lactation and Pregnancy on Bone - Clinical and Basic

    Effects of Lactation and Pregnancy on Bone - Clinical and Basic
    Contains 1 Component(s) Includes a Live Web Event on 07/21/2026 at 2:00 PM (EDT)

    Join Dr. Christopher Kovacs as they discuss "Effects of Lactation and Pregnancy on Bone - Clinical and Basic"

    Join Dr. Christopher Kovacs as they discuss "Effects of Lactation and Pregnancy on Bone - Clinical and Basic" 

    Learning Objectives: 

    1. Review how mineral and bone metabolism adapts during pregnancy and lactation to meet the fetal and neonatal demands for minerals, and the impact that these changes normally have on the healthy maternal skeleton.

    2. Appreciate what systematic reviews have revealed about the epidemiology, risk factors, and recurrence rates for skeletal fragility that presents for the first time during pregnancy and especially lactation.

    3. Determine a reasonable evidence-based approach to diagnosing and treating skeletal fragility during pregnancy and lactation.

    4. Understand the uncertainties about when and if pharmacological therapy may be indicated for this rare condition and if so, which treatments might be used.

  • Product Image: Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics

    Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics
    Contains 1 Component(s) Includes a Live Web Event on 06/26/2026 at 11:00 AM (EDT)

    Join Dr. Marco Brotto as they discuss "Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics" moderated by Dr. Kamal Awad.

    Join Dr. Marco Brotto as they discuss "Elucidating muscle–bone crosstalk: the power of lipidomics and metabolomics" moderated by Dr. Kamal Awad.

    Learning Objectives:
    1. Describe the biological basis of muscle–bone crosstalk in aging and musculoskeletal disease.

    2. Explain how lipidomics and metabolomics can reveal pathways and biomarkers relevant to osteosarcopenia.

    3. Discuss the translational potential of these approaches for identifying clinically useful biomarkers and therapeutic targets in musculoskeletal disorders.

    This webinar is hosted by the ASBMR Muscle and Bone Disease Scientific Interest Group (SIG). The Scientific Interest Groups, brought to you by the Membership Engagement Committee (MEC), aim to empower members through fostering meaningful engagement and collaboration within specific research areas. SIGs are dedicated to promoting year-round connectivity, enhancing networking opportunities, and facilitating mentorship that advances careers. By ensuring inclusivity for all members, SIGs strive to provide exclusive benefits that extend beyond our Annual Meeting, creating a vibrant and supportive community for all.

    Dr. Marco Brotto

    Dr. Marco Brotto

    BSN, MPharm, PhD

    Bone-Muscle Research Center, Institute of Biomanufacturing and Precision Medicine for North Texas (IMPRINT), College of Nursing and Innovation, University of Texas at Arlington

    Dr. Marco Brotto is the George W. & Hazel M. Jay Endowed Professor and Director of the Bone-Muscle Research Center at the University of Texas at Arlington. He is a clinician-scientist with expertise in muscle physiology, cell biology, and translational research models. His work spans experimental platforms ranging from intact muscle and single-muscle fibers to FDA-aligned analytical chemistry approaches. In this webinar, Dr. Brotto will discuss key concepts in muscle–bone crosstalk and highlight how lipidomics and metabolomics can be used to identify blood, serum, fat, muscle, and tissue biomarkers of age-related decline in musculoskeletal function, including osteosarcopenia, as well as other musculoskeletal disorders.

     

    Dr. Kamal Awad

    Dr. Kamal Awad (Moderator)

    Assistant Professor of Research

    The Bone-Muscle Research Center, College of Nursing and Health Innovations, at the University of Texas at Arlington

  • Product Image: Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias

    Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias
    Contains 1 Component(s) Includes a Live Web Event on 06/03/2026 at 2:00 PM (EDT)

    Join Prof. Uwe Kornak and Dr. Natasha Appelman-Dijkstra as they discuss " Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias" moderated by Dr. Michael Collins.

    Join Prof. Uwe Kornak and Dr. Natasha Appelman-Dijkstra as they discuss " Clinical and Molecular Aspects of Osteopetrosis and SOST-Related Sclerosing Bone Dysplasias" moderated by Dr. Michael Collins.

    Learning objectives:

    1. Classification and differential diagnosis of sclerosing skeletal dysplasias
    2. Pathophysiological mechanisms underlying osteopetrosis and SOST-related disorders and clinical consequences
    3. Clinical burden, patient management strategies, and emerging therapeutic approaches for osteopetrosis and SOST-related disorders

     

    Dr. Natasha Appelman-Dijkstra

    Dr. Natasha Appelman-Dijkstra

    Dr. Natasha Appelman-Dijkstra is a  Internist-endocrinologist and full professor Internal Medicine in particular Bone and Mineral Disorders at Leiden University. Coordinator of the European Registries of Rare Endocrine and Bone disorders. 

    Prof. Uwe Kornak

    Prof. Uwe Kornak

    Institute of Human Genetics University Medical Center Göttingen, Germany

    After studying biochemistry and medicine in Berlin and Hamburg Uwe Kornak did his PhD at the Center for Molecular Neurobiology Hamburg, where he started working on osteopetrosis. After that, he did a postdoc in Paris before joining the Max Planck Institute for Molecular Genetics and the Institute for Medical Genetics at Charité-Universitätsmedizin Berlin in 2003. After establishing a research group at the BIH Centre for Regenerative Therapies (BCRT) and the Charité he finished his clinical specialization in human genetics and became Professor for Mechanisms of Genetics Diseases in 2011. He was deputy director of the institute of Medical Genetics and Human Genetics at Charité and of the genetic diagnostics department at Labor Berlin GmbH. In 2020 he moved to the University Medical Center Göttingen to become head of the Department for Medical Genetics at the Institute of Human Genetics, where he established an interdisciplinary Center for Rare Skeletal Disorders. Uwe Kornak participated in many national and international research consortia on rare skeletal and metabolic disorders. After he had participated in the identification of numerous genes for skeletal disorders he is now focussing on diagnostics, disease mechanisms and therapeutic strategies.

    Dr. Michael Collins

    Dr. Michael Collins (Moderator)

  • Product Image: ESI Clinical Case Workshop on Weight Loss Therapies and Their Potential Effects

    ESI Clinical Case Workshop on Weight Loss Therapies and Their Potential Effects
    Contains 1 Component(s)

    Emerging weight loss therapies and potential effects on body composition and fracture risk <br>Speakers: David Scott PhD, BHM, FASBMR., and Jakub Mesinovic, PhD<br> Wednesday 05/20/2026 at 8:30 AM EST

    Description

    Topic: Emerging weight loss therapies and potential effects on body composition and fracture risk Learning Objectives: 1. Recognize the impact of pharmacologically induced weight loss on body composition, with a focus on the potential risks of significant lean mass losses in vulnerable populations. 2. Develop understanding of current evidence regarding the skeletal consequences of intensive weight management on bone mineral density, bone microarchitecture, and fracture risk. 3. Apply practical, evidence-informed strategies to preserve muscle and bone during weight loss therapy, alongside approaches to identifying individuals who require closer musculoskeletal surveillance.

    Speakers: David Scott PhD, BHM, FASBMR., and Jakub Mesinovic, PhD

    Wednesday 05/20/2026 at 8:30 AM EST

  • Product Image: Gene Editing in Cells and Mice

    Gene Editing in Cells and Mice
    Contains 1 Component(s) Recorded On: 05/22/2026

    ASBMR 2018 Webinar: Gene Editing in Cells and Mice

    ASBMR 2018 Webinar: Gene Editing in Cells and Mice

  • Product Image: When Can We Stop Osteoporosis Treatment?

    When Can We Stop Osteoporosis Treatment?
    Contains 1 Component(s) Recorded On: 04/30/2026

    On Tuesday, April 13, 2021 from 1:00 pm EST - 2:00 pm EST, Dr. Richard Eastell, MD, FRCP, FRCPath, FMedSci and Dr. Lorenza Mattia of the University of Sheffield, UK present on the topic "When can we stop osteoporosis treatment?"

    Dr. Richard Eastell, MD, FRCP, FRCPath, FMedSci and Dr. Lorenza Mattia of the University of Sheffield, UK present on the topic "When can we stop osteoporosis treatment?"

  • Product Image: Women's History Month Virtual Panel Discussion on Topics in Mentoring

    Women's History Month Virtual Panel Discussion on Topics in Mentoring
    Contains 1 Component(s)

    ASBMR President Peter Ebeling and President-Elect Mary Bouxsein, "How Mentoring Impacted My Career Path"; Jillian Cornish, Ph.D., "How to be a Successful Mentor" Nancy Lane, M.D., "Mentoring in Academia = Ways Your Institute or Society Can Support You", Sherri-Ann Burnett-Bowie, M.D., M.P.H, "Tips for Mentees in the Clinical Environment"

    ASBMR President Peter Ebeling and President-Elect Mary Bouxsein, "How Mentoring Impacted My Career Path"; Jillian Cornish, Ph.D., "How to be a Successful Mentor" Nancy Lane, M.D., "Mentoring in Academia = Ways Your Institute or Society Can Support You", Sherri-Ann Burnett-Bowie, M.D., M.P.H, "Tips for Mentees in the Clinical Environment"

  • Product Image: Hypoparathyroidism and Genetic Testing

    Hypoparathyroidism and Genetic Testing
    Contains 1 Component(s)

    In this session you will discover how both common and rare genetic variants contribute to the condition, explore current testing technologies and learn practical strategies for choosing and interpreting genetic tests.

    This webinar was sponsored by BridgeBio Pharma, Inc. In this session you will discover how both common and rare genetic variants contribute to the condition, explore current testing technologies and learn practical strategies for choosing and interpreting genetic tests. By the end of the session, develop a solid understanding of the genetic factors behind hypoparathyroidism and know how to apply best practices when selecting, ordering and interpreting genetic tests.

    This webinar was hosted by the Education Advisory Committee. 

  • Product Image: Hypophosphatemic Rickets: From Bench to Bedside

    Hypophosphatemic Rickets: From Bench to Bedside
    Contains 5 Component(s)

    Hypophosphatemic Rickets: From Bench to Bedside

    Component List:

    • Primer (9th edition) Chapter 25: FGF23 and the Regulation of Phosphorus Metabolism
    • Primer (9th edition) Chapter 88: Disorders of Phosphate Homeostasis
    • Webinar: X-Linked Hypophosphatemia: Natural History, Mechanistic Insights and Therapeutic Advances, Thomas O. Carpenter, M.D. (2019); Clinical Case Workshop on Treatment of Adult XLH
    • JBMR Article: Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia
    • JBMR Article: Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets
    • JBMR Article: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
    • JBMR Article: Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X-Linked Hypophosphatemia: Results From the Phase 3, Single-Arm International Trial